Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Transcription factor Foxo3 controls the magnitude of T cell immune responses by modulating the function of dendritic cells.

Dejean AS, Beisner DR, Ch'en IL, Kerdiles YM, Babour A, Arden KC, Castrillon DH, DePinho RA, Hedrick SM.

Nat Immunol. 2009 May;10(5):504-13. doi: 10.1038/ni.1729. Epub 2009 Apr 12.

2.

FoxO1 haploinsufficiency protects against high-fat diet-induced insulin resistance with enhanced peroxisome proliferator-activated receptor gamma activation in adipose tissue.

Kim JJ, Li P, Huntley J, Chang JP, Arden KC, Olefsky JM.

Diabetes. 2009 Jun;58(6):1275-82. doi: 10.2337/db08-1001. Epub 2009 Mar 16.

3.

Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation.

Dengler HS, Baracho GV, Omori SA, Bruckner S, Arden KC, Castrillon DH, DePinho RA, Rickert RC.

Nat Immunol. 2008 Dec;9(12):1388-98. doi: 10.1038/ni.1667. Epub 2008 Nov 2.

4.

Guilt by association: PAX3-FOXO1 regulates gene expression through selective destabilization of the EGR1 transcription factor.

Roeb W, Boyer A, Cavenee WK, Arden KC.

Cell Cycle. 2008 Apr 1;7(7):837-41. Epub 2008 Jan 22. Erratum in: Cell Cycle. 2008 Oct;7(19):3106.

PMID:
18414034
5.

FOXO animal models reveal a variety of diverse roles for FOXO transcription factors.

Arden KC.

Oncogene. 2008 Apr 7;27(16):2345-50. doi: 10.1038/onc.2008.27. Review.

PMID:
18391976
6.

Genome-wide mapping and analysis of active promoters in mouse embryonic stem cells and adult organs.

Barrera LO, Li Z, Smith AD, Arden KC, Cavenee WK, Zhang MQ, Green RD, Ren B.

Genome Res. 2008 Jan;18(1):46-59. Epub 2007 Nov 27.

7.

PAX3-FOXO1 controls expression of the p57Kip2 cell-cycle regulator through degradation of EGR1.

Roeb W, Boyer A, Cavenee WK, Arden KC.

Proc Natl Acad Sci U S A. 2007 Nov 13;104(46):18085-90. Epub 2007 Nov 6.

8.

FoxOs in tumor suppression and stem cell maintenance.

Arden KC.

Cell. 2007 Jan 26;128(2):235-7. Review.

9.

Transgenic mice expressing PAX3-FKHR have multiple defects in muscle development, including ectopic skeletal myogenesis in the developing neural tube.

Finckenstein FG, Davicioni E, Osborn KG, Cavenee WK, Arden KC, Anderson MJ.

Transgenic Res. 2006 Oct;15(5):595-614. Epub 2006 Sep 2.

PMID:
16952014
10.

Multiple roles of FOXO transcription factors in mammalian cells point to multiple roles in cancer.

Arden KC.

Exp Gerontol. 2006 Aug;41(8):709-17. Epub 2006 Jun 27. Review.

PMID:
16806782
11.

Ablation of PDK1 in pancreatic beta cells induces diabetes as a result of loss of beta cell mass.

Hashimoto N, Kido Y, Uchida T, Asahara S, Shigeyama Y, Matsuda T, Takeda A, Tsuchihashi D, Nishizawa A, Ogawa W, Fujimoto Y, Okamura H, Arden KC, Herrera PL, Noda T, Kasuga M.

Nat Genet. 2006 May;38(5):589-93. Epub 2006 Apr 23.

PMID:
16642023
12.

FoxO: linking new signaling pathways.

Arden KC.

Mol Cell. 2004 May 21;14(4):416-8. Review.

13.
14.

Disruption of forkhead transcription factor (FOXO) family members in mice reveals their functional diversification.

Hosaka T, Biggs WH 3rd, Tieu D, Boyer AD, Varki NM, Cavenee WK, Arden KC.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):2975-80. Epub 2004 Feb 20.

15.

The forkhead transcription factor Foxo1 regulates adipocyte differentiation.

Nakae J, Kitamura T, Kitamura Y, Biggs WH 3rd, Arden KC, Accili D.

Dev Cell. 2003 Jan;4(1):119-29.

16.

The forkhead transcription factor Foxo1 links insulin signaling to Pdx1 regulation of pancreatic beta cell growth.

Kitamura T, Nakae J, Kitamura Y, Kido Y, Biggs WH 3rd, Wright CV, White MF, Arden KC, Accili D.

J Clin Invest. 2002 Dec;110(12):1839-47.

18.

Regulation of insulin action and pancreatic beta-cell function by mutated alleles of the gene encoding forkhead transcription factor Foxo1.

Nakae J, Biggs WH 3rd, Kitamura T, Cavenee WK, Wright CV, Arden KC, Accili D.

Nat Genet. 2002 Oct;32(2):245-53. Epub 2002 Sep 3.

PMID:
12219087
19.

Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling.

Arden KC, Biggs WH 3rd.

Arch Biochem Biophys. 2002 Jul 15;403(2):292-8. Review. No abstract available.

PMID:
12139979
20.

Analysis of the regulation of the A33 antigen gene reveals intestine-specific mechanisms of gene expression.

Johnstone CN, White SJ, Tebbutt NC, Clay FJ, Ernst M, Biggs WH, Viars CS, Czekay S, Arden KC, Heath JK.

J Biol Chem. 2002 Sep 13;277(37):34531-9. Epub 2002 Jul 11.

21.

Is annexin 7 a tumor suppressor gene in prostate cancer?

Cardó-Vila M, Arden KC, Cavenee WK, Pasqualini R, Arap W.

Pharmacogenomics J. 2001;1(2):92-4. No abstract available.

22.
23.
24.

Embryonic expression of the tumor-associated PAX3-FKHR fusion protein interferes with the developmental functions of Pax3.

Anderson MJ, Shelton GD, Cavenee WK, Arden KC.

Proc Natl Acad Sci U S A. 2001 Feb 13;98(4):1589-94.

25.

Assignment of seta to distal mouse X chromosome by radiation hybrid mapping.

Hyatt MA, Sykes VW, Boyer AD, Arden KC, Bögler O.

Cytogenet Cell Genet. 2000;89(3-4):278. No abstract available.

PMID:
10965144
26.

Assignment of ankyrin repeat, family A (RFXANK-like) 2 (ANKRA2) to human chromosome 5q12-->q13 by radiation hybrid mapping and somatic cell hybrid PCR.

Rader K, Boyer AD, Farquhar MG, Arden KC.

Cytogenet Cell Genet. 2000;89(3-4):164-5. No abstract available.

PMID:
10965114
27.

ADAMTS9, a novel member of the ADAM-TS/ metallospondin gene family.

Clark ME, Kelner GS, Turbeville LA, Boyer A, Arden KC, Maki RA.

Genomics. 2000 Aug 1;67(3):343-50.

PMID:
10936055
28.

CT10: a new cancer-testis (CT) antigen homologous to CT7 and the MAGE family, identified by representational-difference analysis.

Güre AO, Stockert E, Arden KC, Boyer AD, Viars CS, Scanlan MJ, Old LJ, Chen YT.

Int J Cancer. 2000 Mar 1;85(5):726-32.

29.
30.

Isolation of DICE1: a gene frequently affected by LOH and downregulated in lung carcinomas.

Wieland I, Arden KC, Michels D, Klein-Hitpass L, Böhm M, Viars CS, Weidle UH.

Oncogene. 1999 Aug 12;18(32):4530-7.

31.

Characterization of the GAGE genes that are expressed in various human cancers and in normal testis.

De Backer O, Arden KC, Boretti M, Vantomme V, De Smet C, Czekay S, Viars CS, De Plaen E, Brasseur F, Chomez P, Van den Eynde B, Boon T, van der Bruggen P.

Cancer Res. 1999 Jul 1;59(13):3157-65.

32.

Protein kinase B/Akt-mediated phosphorylation promotes nuclear exclusion of the winged helix transcription factor FKHR1.

Biggs WH 3rd, Meisenhelder J, Hunter T, Cavenee WK, Arden KC.

Proc Natl Acad Sci U S A. 1999 Jun 22;96(13):7421-6.

33.
34.

Isoforms of the human PDZ-73 protein exhibit differential tissue expression.

Scanlan MJ, Williamson B, Jungbluth A, Stockert E, Arden KC, Viars CS, Gure AO, Gordan JD, Chen YT, Old LJ.

Biochim Biophys Acta. 1999 Apr 14;1445(1):39-52.

PMID:
10209257
35.

Localization of serine kinases, SRPK1 (SFRSK1) and SRPK2 (SFRSK2), specific for the SR family of splicing factors in mouse and human chromosomes.

Wang HY, Arden KC, Bermingham JR Jr, Viars CS, Lin W, Boyer AD, Fu XD.

Genomics. 1999 Apr 15;57(2):310-5.

PMID:
10198174
36.

Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.

Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME.

Cell. 1999 Mar 19;96(6):857-68.

37.
38.
39.

Elevated cyclins and cyclin-dependent kinase activity in the rhabdomyosarcoma cell line RD.

Knudsen ES, Pazzagli C, Born TL, Bertolaet BL, Knudsen KE, Arden KC, Henry RR, Feramisco JR.

Cancer Res. 1998 May 1;58(9):2042-9.

40.

Identification of a new MAGE gene with tumor-specific expression by representational difference analysis.

Lucas S, De Smet C, Arden KC, Viars CS, Lethé B, Lurquin C, Boon T.

Cancer Res. 1998 Feb 15;58(4):743-52.

41.

Cloning and characterization of three human forkhead genes that comprise an FKHR-like gene subfamily.

Anderson MJ, Viars CS, Czekay S, Cavenee WK, Arden KC.

Genomics. 1998 Jan 15;47(2):187-99.

PMID:
9479491
42.

Genetic instability leads to loss of both p53 alleles in a human glioblastoma.

Albertoni M, Daub DM, Arden KC, Viars CS, Powell C, Van Meir EG.

Oncogene. 1998 Jan 22;16(3):321-6.

43.

Chromosomal mapping and mutational analysis of the coding region of the glycogen synthase kinase-3alpha and beta isoforms in patients with NIDDM.

Hansen L, Arden KC, Rasmussen SB, Viars CS, Vestergaard H, Hansen T, Møller AM, Woodgett JR, Pedersen O.

Diabetologia. 1997 Aug;40(8):940-6.

PMID:
9267989
44.

Further evidence for ultraviolet light induction of CDKN2 (p16INK4) mutations in sporadic melanoma in vivo.

Herbst RA, Gutzmer R, Matiaske F, Mommert S, Kapp A, Weiss J, Arden KC, Cavenee WK.

J Invest Dermatol. 1997 Jun;108(6):950. No abstract available.

45.

Genomic cloning and localization of CTAG, a gene encoding an autoimmunogenic cancer-testis antigen NY-ESO-1, to human chromosome Xq28.

Chen YT, Boyer AD, Viars CS, Tsang S, Old LJ, Arden KC.

Cytogenet Cell Genet. 1997;79(3-4):237-40.

PMID:
9605863
46.
47.

Detection of the t(2;13) chromosomal translocation in alveolar rhabdomyosarcoma using the reverse transcriptase-polymerase chain reaction.

Arden KC, Anderson MJ, Finckenstein FG, Czekay S, Cavenee WK.

Genes Chromosomes Cancer. 1996 Aug;16(4):254-60.

PMID:
8875239
48.

Allelic deletion mapping on chromosome 5 in human carcinomas.

Wieland I, Böhm M, Arden KC, Ammermüller T, Bogatz S, Viars CS, Rajewsky MF.

Oncogene. 1996 Jan 4;12(1):97-102.

PMID:
8552404
49.

The IL-9 receptor gene (IL9R): genomic structure, chromosomal localization in the pseudoautosomal region of the long arm of the sex chromosomes, and identification of IL9R pseudogenes at 9qter, 10pter, 16pter, and 18pter.

Kermouni A, Van Roost E, Arden KC, Vermeesch JR, Weiss S, Godelaine D, Flint J, Lurquin C, Szikora JP, Higgs DR, et al.

Genomics. 1995 Sep 20;29(2):371-82.

PMID:
8666384
50.

Chromosomal localization of mouse and human genes encoding the splicing factors ASF/SF2 (SFRS1) and SC-35 (SFRS2).

Bermingham JR Jr, Arden KC, Naumova AK, Sapienza C, Viars CS, Fu XD, Khotz J, Manley JL, Rosenfeld MG.

Genomics. 1995 Sep 1;29(1):70-9.

PMID:
8530103

Supplemental Content

Loading ...
Support Center